Hongxin Biology
Shenzhen
About Hongxin Biology
Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $14.0M
- Funding stage: Seed
- Last round: Seed (Aug 2025)
- Website: magicrna.com
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/hongxin-biology-92408 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.